Suppr超能文献

宿主-肿瘤关系XXXIII。癌症患者血清中透明质酸酶抑制剂。

Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients.

作者信息

Kolárová M

出版信息

Neoplasma. 1975;22(4):435-9.

PMID:630
Abstract

Inhibiting activity of blood serum was determined from the decrease of N-acetyl-hexosamine end groups of hyaluronic acid products released by testicular hyaluronidase. Maximum inhibition was observed within the region of pH from 6.5 to 6.8. Correlation between the serum concentration and its inhibiting effect on hyaluronidase was found within the range of the final dilution of serum (in the reaction mixture) from 9 to 45 X. Blood sera of cancer patients showed statistically significant increase of hyaluronidase inhibitor as compared with that of health people.

摘要

通过测定睾丸透明质酸酶释放的透明质酸产物中N-乙酰己糖胺末端基团的减少来确定血清的抑制活性。在pH值为6.5至6.8的范围内观察到最大抑制作用。在血清(反应混合物中)最终稀释度为9至45倍的范围内,发现血清浓度与其对透明质酸酶的抑制作用之间存在相关性。与健康人相比,癌症患者的血清中透明质酸酶抑制剂有统计学意义的增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验